Mia's Feed
Medical News & Research

The Impact of Fat Distribution on Cancer Risk: New Research Findings

The Impact of Fat Distribution on Cancer Risk: New Research Findings

Share this article

Recent research suggests that where fat is stored in the body significantly impacts the risk of developing various cancers, emphasizing the importance of fat distribution over BMI alone.

2 min read

A recent study led by the University of Bristol highlights that the way fat is distributed across the body may significantly influence the risk of developing certain cancers. Published in the JNCI: Journal of the National Cancer Institute, this research investigates the complex relationship between body fat location and various obesity-related cancers.

While it is well-established that obesity increases the likelihood of some cancers, traditionally measured using Body Mass Index (BMI), emerging evidence suggests that BMI alone may not fully capture health risks associated with excess fat. Specifically, scientists are now exploring how fat stored in different regions of the body impacts cancer susceptibility.

The study utilized Mendelian randomization, a technique that leverages genetic variations to identify causal relationships within large health datasets. The researchers examined whether fat deposited in specific areas—such as the abdomen, hips, or thighs—affects the risk for 12 types of obesity-related cancers including endometrial, ovarian, breast, colorectal, pancreatic, multiple myeloma, liver, kidney, thyroid, gallbladder, esophageal adenocarcinoma, and meningioma.

Findings indicate that fat distribution plays a crucial role, with the impact varying across different cancers. For some, where fat accumulates matters most; for others, the overall amount of fat is more significant. Additionally, the specific body regions where fat is stored influencing cancer risk appear to differ depending on the cancer type, reflecting a complex interplay.

Lead author Dr. Emma Hazelwood explained that these results reinforce the notion that BMI should not be the sole measure of obesity-related health risks. Instead, more personalized assessments considering fat distribution could improve risk prediction and prevention strategies. This aligns with recent calls from the European Association for the Study of Obesity and the Lancet Commission, emphasizing that fat distribution is a key factor in assessing obesity-related health outcomes.

The research paves the way for future investigations into the biological mechanisms linking fat depots to cancer development. Understanding how different types of fat influence tumor formation could lead to more targeted interventions. The team advocates for further studies incorporating diverse populations to enhance the generalizability of these findings.

In conclusion, these insights highlight the importance of looking beyond BMI to understand cancer risk. Recognizing the role of fat distribution may help identify individuals at higher risk and guide more effective, personalized approaches to obesity management and cancer prevention.

Source: https://medicalxpress.com/news/2025-09-fat-cancer.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Fact Check: Is Autism on the Rise and What Are the Causes?

Experts clarify that the rise in autism diagnoses is mainly due to improved awareness, broader diagnostic criteria, and enhanced screening, not an actual epidemic. Learn the facts behind recent claims and environmental factors involved.

New RNA Regulatory Network Identified in Colorectal Cancer Progression and Immune Response

Researchers have identified a key RNA-driven regulatory network that influences colorectal cancer progression and immune response, offering new therapeutic targets to improve treatment resistance. Learn more about this groundbreaking study.

Innovative Map of Tumor Cells Enhances Personalized Brain Cancer Therapies

Researchers at City of Hope have developed a detailed map of tumor cells, shedding light on the role of extrachromosomal DNA in brain cancer progression and paving the way for more personalized treatments.